We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Cap. Flow
-$5.51B
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
1,739
New
42
Increased
177
Reduced
1,384
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$201M |
| 2 |
Oracle
ORCL
|
+$135M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$267M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 3 |
NVIDIA
NVDA
|
+$172M |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Scansource
SCSC
$1.16B
| – | – |
-2,296
| Closed | -$101K |
|
|
SEE
1727
DELISTED
Sealed Air
SEE
| – | – |
-24,934
| Closed | -$881K |
|
|
THS
1728
DELISTED
Treehouse Foods
THS
| – | – |
-19,606
| Closed | -$396K |
|
1729
TPG
TPG
$6.97B
| – | – |
-13,240
| Closed | -$761K |
|
1730
Usana Health Sciences
USNA
$427M
| – | – |
-6,445
| Closed | -$178K |
|
|
VRNA
1731
DELISTED
Verona Pharma
VRNA
| – | – |
-58,863
| Closed | -$6.28M |
|
1732
Wave Life Sciences
WVE
$1.13B
| – | – |
-313,307
| Closed | -$2.29M |
|
1733
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
| – | – |
-30,406
| Closed | -$1.36M |
|
1734
Xerox
XRX
$357M
| – | – |
-38,930
| Closed | -$146K |
|
|
DAY
1735
DELISTED
Dayforce
DAY
| – | – |
-9,207
| Closed | -$634K |
|
1736
Skye Bioscience
SKYE
$21.4M
| – | – |
-767,287
| Closed | -$3.02M |
|
|
ATYR
1737
aTyr Pharma
ATYR
$47.6M
| – | – |
-414,732
| Closed | -$299K |
|
|
NBIS
1738
Nebius Group N.V.
NBIS
$42.3B
| $0 | ﹤0.01% |
22,300
| – | – |
|
|
MTSR
1739
DELISTED
Metsera Inc
MTSR
| – | – |
-107,318
| Closed | -$5.62M |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Ensign Peak Advisors held 1,739 positions worth $56.6B, down 7.1% from $60.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ensign Peak Advisors withdrew a net $5.51B in Q4 2025, closing 54 positions and reducing 1,384 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in Invesco MSCI USA ETF worth $81.3M.
- Ensign Peak Advisors's largest Q4 2025 buy was Invesco MSCI USA ETF: 1,188,232 shares worth $81.3M.
- Ensign Peak Advisors added most to Eli Lilly in Q4 2025, an estimated $201M increase.
- Ensign Peak Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $267M.
- Ensign Peak Advisors fully exited iShares Core S&P 500 ETF in Q4 2025, selling an estimated $125M.
- Ensign Peak Advisors's ten largest holdings make up 37% of its $56.6B portfolio in Q4 2025.
- Ensign Peak Advisors opened 42 new positions and closed 54 in Q4 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $56.6B.
Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.